463941-07-3 Usage
Description
(S)-O-TOLYL-CBS-OXAZABOROLIDINE, 0.5M I& is a chiral catalyst with a unique structure that plays a crucial role in various organic reactions. It is characterized by its ability to selectively promote specific reactions, leading to the formation of desired products with high enantiomeric purity. This property makes it a valuable tool in the field of asymmetric synthesis, where the production of enantiomerically pure compounds is of great importance.
Uses
Used in Pharmaceutical Industry:
(S)-O-TOLYL-CBS-OXAZABOROLIDINE, 0.5M I& is used as a chiral catalyst for enantioselective reactions in the synthesis of pharmaceutical compounds. The high enantioselectivity of this catalyst allows for the production of enantiomerically pure drugs, which is essential for ensuring the desired therapeutic effects and minimizing potential side effects.
Used in Chemical Industry:
In the chemical industry, (S)-O-TOLYL-CBS-OXAZABOROLIDINE, 0.5M I& is used as a chiral catalyst for enantioselective reactions in the synthesis of various fine chemicals, agrochemicals, and specialty chemicals. The ability of this catalyst to selectively promote specific reactions with high enantiomeric purity makes it a valuable tool for the production of high-quality products with improved performance and reduced environmental impact.
Used in Research and Development:
(S)-O-TOLYL-CBS-OXAZABOROLIDINE, 0.5M I& is also used in research and development laboratories for the investigation of new synthetic routes and the development of novel chiral compounds. Its high enantioselectivity and versatility make it an ideal catalyst for exploring new reaction pathways and discovering new chiral molecules with potential applications in various fields, such as pharmaceuticals, materials science, and agrochemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 463941-07-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,3,9,4 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 463941-07:
(8*4)+(7*6)+(6*3)+(5*9)+(4*4)+(3*1)+(2*0)+(1*7)=163
163 % 10 = 3
So 463941-07-3 is a valid CAS Registry Number.
InChI:InChI=1/C24H24BNO/c1-19-11-8-9-16-22(19)25-26-18-10-17-23(26)24(27-25,20-12-4-2-5-13-20)21-14-6-3-7-15-21/h2-9,11-16,23H,10,17-18H2,1H3/t23-/m0/s1
463941-07-3Relevant articles and documents
Useful Applications of Enantioselective (4 + 2)-Cycloaddition Reactions to the Synthesis of Chiral 1,2-Amino Alcohols, 1,2-Diamines, and β-Amino Acids
Mahender Reddy, Karla,Thirupathi, Barla,Corey
, p. 4956 - 4959 (2017)
The scope of enantioselective (4 + 2)-cycloaddition reactions has been expanded to include reactive olefinic components that are equivalents of three inoperable and unstable ethylene derivatives: 1-hydroxy-2-aminoethylene, 1,2-diaminoethylene, and β-amino
Asymmetric synthesis of (+)-cis-nemorensic acid from a chiral Diels-Alder adduct of 2,5-dimethylfuran
Sim, Jae Yi,Hwang, Geum-Sook,Kim, Kyung Hwa,Ko, Eun Mi,Ryu, Do Hyun
, p. 5064 - 5065 (2007)
(+)-cis-Nemorensic acid (1) was synthesized from a chiral Diels-Alder adduct (4) prepared by a catalytic enantioselective Diels-Alder reaction with 2,5-dimethylfuran and 2,2,2-trifluoroethyl acrylate. The Royal Society of Chemistry.
Enantioselective Strecker and Allylation Reactions with Aldimines Catalyzed by Chiral Oxazaborolidinium Ions
Kang, Ki-Tae,Park, Sang Hyun,Ryu, Do Hyun
supporting information, p. 6679 - 6683 (2019/09/12)
Chiral oxazaborolidinium ion (COBI)-catalyzed enantioselective nucleophilic addition reactions of aldimines using tributyltin cyanide and allyltributylstannane have been developed. Various α-aminonitriles and homoallylic amines were synthesized in high yi
SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE
-
Paragraph 0651; 0652, (2015/08/04)
Provided herein are formulations, processes, solid forms and methods of use relating to 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide.
